Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis
Background Lemierre syndrome is a potentially life-threatening disease, which affects otherwise healthy young adults and adolescents. It is characterized by acute neck vein thrombosis and septic embolism, usually complicating a bacterial infection. Data on the syndrome are sparse, particularly concerning arterial complications.
Methods We evaluated the frequency and patterns of cerebral arterial and cardiac involvement (“arterial complications”) in an individual patient level cohort of 712 patients, representing all cases described over the past 20 years in the medical literature who fulfilled the criteria: (1) bacterial infection in the neck/head site and (2) objectively confirmed thrombotic complication or septic embolism. The study outcomes were defined as all-cause in-hospital deaths and the occurrence of clinical sequelae at discharge or in the postdischarge period.
Results A total of 55 (7.7%) patients had an arterial complication. The most frequent arterial complications were carotid involvement (52.7%), stroke (38.2%), and pericardial complications (20%). Patients with an arterial involvement were more likely to be treated with a greater number of antibiotics (23 vs. 10%) and to receive anticoagulation. In addition, patients with arterial complications had a greater risk of all-cause death (n = 20/600, 3.3% vs. n = 6/52, 12%; odds ratio [OR]: 3.8; 95% confidence interval [CI]: 1.5–9.9) and late clinical sequelae (n = 49/580, 9.0% vs. n = 15/46, 35%; OR: 5.2; 95% CI: 2.65–10.37).
Conclusions While Lemierre syndrome is known to be primarily characterized by venous thromboembolic events, our results suggest that local or distant arterial complications may occur in approximately one-tenth of patients and may be associated with a greater risk of long-term sequelae and death.
KeywordsLemierre syndrome - thrombosis - stroke - septic embolism - anticoagulation - Fusobacterium necrophorum
Eingereicht: 18. Juni 2021
Angenommen: 10. November 2021
Artikel online veröffentlicht:
07. März 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Valerio L, Pleming W, Pecci A, Barco S. Management of Lemierre syndrome. Minerva Med 2021; 113 (06) DOI: 10.23736/S0026-4806.21.07497-8.
- 2 Valerio L, Zane F, Sacco C. et al. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases. J Intern Med 2021; 289 (03) 325-339
- 3 Batty A, Wren MW. Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci 2005; 62 (02) 66-70
- 4 Centor RM, Atkinson TP, Ratliff AE. et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 2015; 162 (04) 241-247
- 5 Brazier JS, Hall V, Yusuf E, Duerden BI. Fusobacterium necrophorum infections in England and Wales 1990-2000. J Med Microbiol 2002; 51 (03) 269-272
- 6 Ramirez S, Hild TG, Rudolph CN. et al. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital. Pediatrics 2003; 112 (05) e380
- 7 Bentham JR, Pollard AJ, Milford CA, Anslow P, Pike MG. Cerebral infarct and meningitis secondary to Lemierre's syndrome. Pediatr Neurol 2004; 30 (04) 281-283
- 8 DeGaffe GH, Murphy JR, Butler IJ, Shelburne J, Heresi GP. Severe narrowing of left cavernous carotid artery associated with Fusobacterium necrophorum infection. Anaerobe 2013; 22: 118-120
- 9 Goyal MK, Kumar G, Burger R. Necrobacillosis resulting in isolated carotid thrombosis and massive stroke: a unique Lemierre variant?. J Neurol Sci 2009; 287 (1-2): 108-110
- 10 Root RW, Barrett TW, Abramo TJA. A 10-month-old with Lemierre syndrome complicated by purulent pericarditis. Am J Emerg Med 2013; 31 (01) 274.e5-274.e7
- 11 Kreuzpointner R, Valerio L, Corsi G. et al. Ophthalmic complications of Lemierre syndrome. Acta Ophthalmol 2021; (epub ahead of print) DOI: 10.1111/aos.14871.
- 12 Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 2016; 25 (14) 1520-1531
- 13 George JN, Raskob GE, Shah SR. et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998; 129 (11) 886-890
- 14 Vazquez FJ, Paulin P, Rodriguez P, Lubertino M, Gándara E. The outcome of pulmonary vein thrombosis in non-surgical patients. A systematic review and case report. Thromb Haemost 2015; 113 (05) 1151-1154
- 15 Sacco C, Zane F, Granziera S. et al; Lemierre Study Group. Lemierre syndrome: clinical update and protocol for a systematic review and individual patient data meta-analysis. Hamostaseologie 2019; 39 (01) 76-86
- 16 Ratnasingham Y, Kristensen LH, Gammelgaard L, Balslev T. Arterial ischemic stroke as a complication to disseminated infection with Fusobacterium necrophorum . Neuropediatrics 2014; 45 (02) 120-122
- 17 Wright WF, Shiner CN, Ribes JA. Lemierre syndrome. South Med J 2012; 105 (05) 283-288
- 18 Jones TH, Bergvall V, Bradshaw JP. Carotid artery stenoses and thrombosis secondary to cavernous sinus thromboses in Fusobacterium necrophorum meningitis. Postgrad Med J 1990; 66 (779) 747-750
- 19 Touitou D, Deltour S, Bonneville F. et al. Hemiplegia in Lemierre syndrome: a neuroimaging strategy. Eur J Neurol 2006; 13 (04) 424-426
- 20 Valerio L, Corsi G, Sebastian T, Barco S. Lemierre syndrome: current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry. Thromb Res 2020; 196: 494-499